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E-mail address: Matthewchang@ntu.edu.sg (M.W.The nucleic acid sequence at the positions 1067817–1066321 of Pseudomonas aeruginosa PAO1 gen-
ome was predicted to encode a novel S-type pyocin, designated S5, based on the genome sequence.
However, its antimicrobial spectrum, activity and mechanism have not been investigated. Herein,
we report that pyocin S5 has an antimicrobial activity against seven clinical P. aeruginosa isolates
(DWW3, InA, InB, In3, In4, In7, and In8). Among them, DWW3 is most sensitive with a minimum
inhibitory concentration of 12.6 lg/ml and a killing percentage of 95.7 at 225 lg/ml. Further, we
demonstrated that the antimicrobial mechanism of pyocin S5 is membrane damage, evidenced by
the leakage of intracellular materials, the increase of membrane permeability, and cell surface
disruption.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bacteriocins are antimicrobial peptides or proteins produced by
strains of diverse bacterial species [1]. Pseudomonas aeruginosa is a
widely-spread environmental bacterium and an opportunistic
pathogen causing acute and chronic infection in immune-compro-
mised individuals, such as cystic ﬁbrosis (CF) patients [2]. More
than 90% of P. aeruginosa strains produce bacteriocins, called pyoc-
ins, which are classiﬁed into three types: R-, F- and S-type. Ecolog-
ically, pyocin production may ensure the predominance of a
producing strain in a bacterial niche upon exposure to mutagenic
agents that provoke DNA damage, such as mitomycin C, UV, and
H2O2 [3–5]. The killing activity of pyocins is initiated by the bind-
ing of pyocins to the speciﬁc outer membrane receptors of the sus-
ceptible cells. Most pyocinogenic strains are insensitive to their
own pyocins mainly because of immunity proteins, which helps
preserve the initial predominance of pyocinogenic bacteria against
pyocin-sensitive cells [6].
The R-type (rod-like) pyocins, related to P2 phage and required
for competitive growth advantage [7], bind their tail ﬁbers to tar-
geted bacterial surface receptors and then kill by forming pores
in the target cell membrane [8]. The F-type (ﬂexible and non-con-
tractible) pyocins are related to k phage with similar structural andchemical Societies. Published by E
Chang).serological properties but different receptor speciﬁcities [7]. The S-
type (soluble) pyocins, including S1, S2, S3, and AP41, possess the
structures and the modes of action similar to those of colicins, bac-
teriocins produced by Escherichia coli [4,9]. The S-type pyocins
have an effector and an immunity component, with the effector
component exerting a killing activity including DNase activity
[10–12]. In general, an effector component of the S-type pyocins,
which has a range of 498–776 amino acids, consists of a receptor
binding domain for receptor binding, a translocation domain for
translocation across the membrane, and a killing domain for a kill-
ing activity. The immunity component, which has 87–153 amino
acids, renders pyocinogenic strains immune to their produced
pyocins. Recently, a novel pyocin from P. aeruginosa JJ692 and
6077 exoU-containing clinical isolates was shown to exhibit colicin
M (ColM)-like hydrolase activity towards peptidoglycan precursors
[9].
The antimicrobial activity andmechanisms of pyocins S1, S2, S3,
and AF41 have been reported. The availability of P. aeruginosa gen-
ome sequences enabled the prediction of additional pyocin genes,
including the nucleic acid sequence at positions 1067817–1066321
(PA0985) in P. aeruginosa PAO1 genome. This predicted pyocin,
designated S5, contains translocation-receptor binding-killing do-
mains (Fig. 1A), and the killing domain shares 46% homology with
that of colicin Ia, a pore-forming bacteriocin [13]. In this study, for
the ﬁrst time, we experimentally demonstrated the antimicrobial
spectrum, activity and mechanism of pyocin S5.lsevier B.V. All rights reserved.
Fig. 1. The pyocin S5 domains, and the secondary structure analysis of pyocin S5 and colicin Ia. (A) A schematic diagram of pyocin S5 domains. (B) The secondary structure of
pyocin S5 (498 amino acids) and colicin Ia from E. coli (626 amino acids, GenBank ID: ZP_02783400.1), analyzed using the Hierarchical Neural Network (HNN) program. The
numbers (i.e. 0, 50, 100, and 150) stand for amino acids (aa) position. The long, middle and short bars represent the amino acids that form helix, sheet and coil, respectively.
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2.1. Bacterial strains and growth conditions
E. coli BL21 (DE3) and Top10 were grown in Luria–Bertani (LB)
broth at 37 C with shaking at 250 rpm. Fifteen P. aeruginosa strains
(In1–8 [14]; InA–E [14]; DWW1, DWW3 [5] (clinical isolates))
were kindly provided by Dr. R.D. Waite at Queen Mary University
of London. P. aeruginosa strains were grown in Mueller–Hinton
broth (MHB) or Tryptone soya broth (TSB) medium at 37 C. Solid
media were prepared by adding 1.5% (wt/vol) agar to the broth.
Tryptone soya agar (TSA) plates and soft agar (1.0% peptone and
0.5% agar) were used for the overlay assay [5].
2.2. Secondary structure of pyocin S5
The Hierarchical Neural Network (HNN) method [15] and the
SOSUI method [16] reportedly provide a high accuracy of protein
structure and trans-membrane protein prediction. The HNN and
SOSUI methods were employed to predict the secondary structure
and transmembrane region of pyocin S5, respectively. The second-
ary structure of colicin Ia (GenBank Acc. No. ZP_02783400.1) was
analyzed by the HNN method for comparison with pyocin S5.
2.3. Overexpression and puriﬁcation of pyocin S5 in E. coli BL21 (DE3)
Pyocin S5 gene (pyoS5, PA0985, 1497 bp, encoding 498 aa) was
synthesized (GeneArt, Germany) and introduced into pET30b (+)
(Merck, Germany) by EcoRI/HindIII double digestion, ligation, and
transformation into E. coli BL21 (DE3). Overexpression of pyocin
S5 was induced for 3 h by adding 1.0 mM IPTG into the cell culture
(OD600 = 0.5–1.0) from a single colony and then, the recombinant
plasmid (pET30b-pyoS5) was harbored. The total protein was ana-
lyzed by SDS–PAGE.
To purify pyocin S5, after induction, the cells were resuspended
in 1 PBS containing 10 mM imidazole (pH 7.4), and lysed by dig-
ital Soniﬁer ultrasonic cell disrupter S-450 (Branson, USA). Thecell debris was separated by centrifugation and ﬁltration. The
cell-free lysate was used for puriﬁcation by His Trap™ HP columns
(GE Healthcare, USA) through Amersham Akta fast protein liquid
chromatography (FPLC) (GE Healthcare). Five-milliliters of
HiTrap™ column (GE Healthcare) was employed to desalt. Finally,
the protein was eluted into the protein sample buffer (10 mM
PO34 , 20% glycerol, pH 6.0). The purity and concentration were
measured by SDS–PAGE and Bradford Assay Kit (Bio-Rad, CA,
USA), respectively.
2.4. Antimicrobial spectrum and bactericidal activity
The antimicrobial spectrum of pyocin S5 was determined
based on the overlay assay as previously described [5,17]. Brieﬂy,
the overlay assay employs bacteria-seeded soft agar as a top
layer covering a bottom layer of agar, with antimicrobial com-
pounds spotted onto the bottom layer, followed by a subsequent
determination of inhibition zones. In our study, TSA plates were
covered by 2.5 ml soft agar containing 100 ll cell cultures at a
log phase (approximately 107 cells/ml) of each of 16 P. aerugin-
osa strains (PAO1, In1–8, InA–E, DWW1, and DWW3), three
E. coli strains (BL21 (DE3), W3110, and ATCC15597) and Staphy-
lococcus aureus ATCC6538. Ten microliters of pyocin S5 protein
with twofold serial dilution was spotted onto the strain lawns.
After overnight incubation at 30 C, inhibition zones on the bac-
terial lawns were examined. Minimum inhibition concentrations
(MICs) were determined as the lowest concentration of puriﬁed
pyocin S5 that induced a clear inhibition zone on the bacterial
lawns [17,18].
To elucidate the effects of pyocin S5 on the viability of P. aeru-
ginosa DWW3, the cells at a middle-log phase were washed three
times and adjusted to an OD600 of 1.0. An aliquot of the cells resus-
pended in sterile 0.9% NaCl was mixed with pyocin S5 at a range of
concentrations (3.5, 14, 56, 225 lg/ml). The mixtures were incu-
bated at 37 C with a shaking at 250 rpm for 20 min, 40 min, or
60 min. The cell aliquots from each time point were collected
and used for the colony forming unit (CFU) counting.
Table 1
MICs of pyocin S5 against P. aeruginosa strains.
Strains DWW3 In7 InA InB In4 In3 In8
MIC (lg/ml) 12.6 50.5 50.5 151.6 202.2 404.4 808.8
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To detect the release of the nucleic acids from the DWW3 cells,
the absorbance at 260 nm (A260) in the cell-free supernatant was
measured after treatment with pyocin S5 (225 lg/ml) by Nano-
Drop (Thermo, USA). ATP release from the cells in the supernatant
was analyzed by BacTiter-Glo™ Microbial Cell Viability Assay Kit
and GloMax™ 20/20 Luminometer (Promega, USA). The control
cells were prepared in the same way but without pyocin S5
treatment.
Furthermore, the cells after the treatment were stained by LIVE/
DEAD BacLight Bacterial Viability Kit (Invitrogen, CA, USA), and
thereafter observed under Carl Zeiss ﬂuorescence microscope Axio
A1 (Zeiss, Germany).
The ﬁeld emission electron scanning microscopy (FESEM) pro-
duces clearer, less electrostatically distorted images compared to
the conventional SEM and has widely been used to observe details
of the cell surface. The cells were washed with 0.1 M sodium cac-
odylate (pH 7.4) after 1 h incubation with pyocin S5 (225 lg/ml).
The ﬁrst ﬁxation was performed with 2.5% glutaraldehyde (GTA)
at 4 C for overnight, followed by washing and the second ﬁxation
with 1.0% osmium tetroxide at room temperature for 1.5 h. The
cells were dehydrated by ethanol (37%, 67%, 95%, and 100%) and
loaded onto silicon slides. After air dry, the cells were observed
using JOEL FESEM JSM-6700F (JOEL, Japan).
3. Results and discussion
3.1. Overexpression and puriﬁcation of pyocin S5
Based on Pseudomonas aeruginosa PAO1 genome sequence
(http://www.pseudomonas.com/), the nucleic acid sequences at
positions 1067817–1066321 (the gene number: PA0985) were pre-
dicted to encode a novel pyocin, designated S5 [13], with 498 ami-
no acids, the killing domain of which shares 46% homology with
that of colicin Ia. In this study, we found 23 alpha-helixes in the
secondary structure of pyocin S5 using the Hierarchical Neural
Network (HNN) method [15], whereas colicin Ia has 24 alpha-
helixes (Fig. 1B). Further, the trans-membrane region prediction
performed by the SOSUI program [16] indicates that pyocin S5
has two trans-membrane helixes close to C-terminus, with theFig. 2. SDS–PAGE analysis of overexpressed and puriﬁed pyocin S5, and the killing kinet
standard (Invitrogen), E. coli BL21 (DE3) (host cell) – harboring pET30b-S5 without and w
of pyocin S5 against P. aeruginosa DWW3.trans-membrane region of PFFVKIETLAAGAAASWLVGIAF and ATA-
TPIGILGFALVMAVTGAMID. As mentioned above, similarly, colicin
Ia has 24 alpha-helixes, which include two trans-membrane he-
lixes near C-terminus (Fig. 1B). This similar secondary structure
and trans-membrane region, together with the 46% homology of
the killing domains, suggests pyocin S5 as a pore-forming
bacteriocin.
Pyocin S5 is reportedly produced under stress conditions caused
by H2O2 [3] and ceftazidime [19] and in bioﬁlm under aerobic and
anaerobic condition [5]. In this study, to express and purify pyocin
S5, pyoS5 gene was chemically synthesized, introduced into
pET30b (+), and the recombinant construct was subsequently
transformed into the host cell E. coli BL21 (DE3). As shown in
Fig. 2A, pyocin S5 was efﬁciently expressed by induction with IPTG.
To facilitate the puriﬁcation, His tag-S tag (around 4.8 kDa) was
fused onto the N-terminus of pyocin S5 (MW 57.6 kDa). After puri-
ﬁcation by FPLC, 2.16 mg/ml of pyocin S5 protein was obtained and
showed a single band at MW 62.4 kDa (Fig. 2A, lane 4).
3.2. Antimicrobial spectrum and kinetics of bactericidal activity
against P. aeruginosa
To determine the antimicrobial spectrum of pyocin S5 and
identify sensitive P. aeruginosa strains, we examined the suscepti-
bility of sixteen P. aeruginosa strains (PAO1, In1–8, InA–E, DWW1,
and DWW3 [5]), three E. coli strains (BL21 (DE3), W3110, and
ATCC15597) and S. aureus ATCC6538. Table 1 shows that seven
P. aeruginosa strains (DWW3, In3, In4, In7, In8, InA, and InB) dis-
played sensitivity to pyocin S5, which showed clear inhibition
zones with diffused boundaries. P. aeruginosa PAO1, E. coli (BL21
(DE3), W3110, and ATCC15597) and S. aureus ATCC6538 were
insensitive to pyocin S5 even at 2.16 mg/ml. This insensitivity of
pyocin S5 might stem from that: (i) those strains have no speciﬁc
receptor on the cell surface and/or no translocation system forics activity against P. aeruginosa DWW3. (A) SDS–PAGE analysis. Lanes 1–4: protein
ith IPTG induction, and pyocin S5 after puriﬁcation. (B) The kinetics of killing activity
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sitive strains might inactivate pyocin S5 action by binding to the C-
terminus of pyocin S5. S5 immunity protein (108 amino acids) en-
coded by PA0984 potentially resides in the inner membrane and
enables speciﬁc intramembrane helix–helix interactions with pyo-
cin S5 to perform immunity. The antimicrobial activity is initiated
by binding of pyocin S5 to its receptor on the sensitive cell mem-
brane. Although several receptors for pore-forming colicins and
other pyocins have been characterized (e.g. Cir, BtuB, FpvA, and
lipopolysaccharide) [9,20–22], the receptor for pyocin S5 remains
unknown. To evaluate the antimicrobial activity of pyocin S5
against different sensitive strains, the MICs were measured. Table
1 shows that among the seven sensitive strains (DWW3, In3, In4,
In7, In8, InA, and InB), DWW3, which is a clinical isolate from cys-
tic ﬁbrosis patients [5], possessed the highest sensitivity to pyocin
S5, with a MIC of 12.6 lg/ml (0.2 lM), which is more than 60 times
lower than that against In8 (Table 1). At the MICs of pyocin S5Fig. 3. Assays used to examine membrane damage of P. aeruginosa DWW3 upon exposure
measurement of absorbance at 260 nm; (B) ATP release from the cells (a relative luminesc
F) cell morphology changes under FESEM. Note that (C) and (E) were from the cells witagainst these sensitive strains, clear inhibition zones with 10–
15 mm diameters and diffused boundaries were observed. To fur-
ther study the killing rate of pyocin S5 against DWW3, colony
forming units (CFUs) were counted during time course (i.e. 20,
40, and 60 min) at 3.5, 14, 56, and 225 lg/ml. Fig. 2B shows that
the killing percentage of pyocin S5 reached 58.9 ± 1.76% after
20 min treatment at 14 lg/ml and was increased to 95.7 ± 0.87%
after 60 min treatment at 225 lg/ml. Additionally, pyocin S5 at
3.5 lg/ml displays at least three times lower killing efﬁcacy than
at 225 lg/ml against DWW3. During the time course, the killing
activity showed a general trend of increase except for that at
3.5 lg/ml of pyocin S5.
3.3. Membrane leakage and permeability
Tokuda et al. [23] proposed that colicin Ia binds to a speciﬁc
outer membrane receptor and is subsequently translocated to theto pyocin S5. (A) The leakage of intracellular components in the supernatant by the
ence unit); (C and D) the SYTO9 (green) and PI (red) staining of the cells; and (E and
hout pyocin S5 exposure.
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colicin Ia in the killing domain [13], we hypothesized that the
mode of action of pyocin S5 might be cytoplasmic membrane dam-
age, which causes the leakage of intracellular materials, the in-
crease of membrane permeability, and membrane disruption.
To investigate the leakage of intracellular materials such as nu-
cleic acids and ATP from DWW3 cells upon exposure to 225 lg/ml
of pyocin S5, absorbance at 260 nm and ATP release in cell-free
supernatant were measured. The control cells were prepared in
the same way but without pyocin S5 treatment. As shown in
Fig. 3A, after exposure to pyocin S5, absorbance at 260 nm is more
than three times higher than that of the control. Since a purine or
pyrimidine base shows characteristic absorbance at 260 nm, this
increase in absorbance at 260 nm indicates the leakage of nucleic
acids from DWW3 cells into the supernatant after exposure to pyo-
cin S5. Similarly, ATP assay shows that the relative luminescence
unit (RLU) in the supernatant after incubation with pyocin S5 for
1 h is more than two times higher than that of the control
(Fig. 3B). The luminescence signal represents luminescent light
intensity after ATP-luciferin reaction catalyzed by luciferase in
the presence of Mg2+, and molecular oxygen. Thus, the increased
RLU in the supernatant represents ATP release from the cells
through membrane damage after exposure to pyocin S5.
Besides the leakage of intracellular materials, a change in mem-
brane permeability is another characteristic of membrane damage.
Fig. 3 shows that most DWW3 cells used as a control are stained
with SYTO9 (green) (Fig. 3C), whereas pyocin S5 addition caused
the majority of the cells to be stained with PI (red) (Fig. 3D). Fluo-
rescent nucleic acid dye SYTO 9 penetrates and labels the bacteria
with intact and damaged membrane; however, PI can only pene-
trate damaged membrane. Therefore, the DWW3 cells stained with
PI (red) represent the cells with damaged membrane.
3.4. Membrane damage observed under FESEM
To further characterize membrane damage caused by pyocin S5,
the cell morphology of DWW3 was examined upon exposure to
pyocin S5 by FESEM. Fig. 3E and F shows that: (i) more than 60%
of the cells shrunk to a smaller size after the exposure, likely due
to the leakage of intracellular materials; (ii) the shape of the major-
ity of the cells became irregular or distorted; and (iii) the cell sur-
face turned very rough with observable protuberances and
concaves. Moreover, the majority of the DWW3 cells exhibited
shrinkage, rough surface and/or distortion after 1 h exposure. This
difference in the cell morphology demonstrates that pyocin S5
caused membrane damage to DWW3 cells.
To summarize, this study has provided the ﬁrst experimental
evidence that the nucleic acid sequences at positions 1067817–
1066321 (PA0985) encode a bacteriocin protein. We have shown
that this bacteriocin, previously designated pyocin S5, is effective
against seven clinical P. aeruginosa strains including DWW3, a clin-
ical isolate from cystic ﬁbrosis patients. Against DWW3, the MIC of
pyocin S5 was 12.6 lg/ml (0.2 lM) and the killing percentage was
95.7% at 225 lg/ml after 60 min exposure. Furthermore, we have
demonstrated that pyocin S5 causes membrane damage to
DWW3, which was evidenced by (i) the increased leakage of intra-
cellular materials, nucleic acids and ATP; (ii) the enhancement of PI
penetration through membrane; and (iii) the shrinkage and distor-
tion of the cell shape, and the rough cell surface. P. aeruginosa
poses a serious health threat to the immunocompromised patients
and also to the public because of its resistance to many synthetic
antibiotics. Given the signiﬁcance of the discovery of antimicrobial
molecules effective against clinical isolates of P. aeruginosa, this
study may suggest the potential use of pyocin S5 for P. aeruginosa
treatment. Further, a speciﬁc binding capability of pyocins to theirreceptors, and the killing mechanism of pyocins can be exploited
for developing a novel treatment regimen that has a low propen-
sity to cause antimicrobial resistance and speciﬁcally targets P.
aeruginosa. Alternatively, this narrow antimicrobial spectrum can
be tailored for broader applications by developing chimeric
pyocins.Acknowledgements
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